All News

2020

March

Media Release / Mar 02, 2020

Sandoz Resolves Generic Drug Antitrust Investigation in the U.S.

Read More

February

Media Release / Feb 26, 2020

Sandoz commits to keep prices stable for basket of essential COVID-19 medicines; Novartis responds to COVID-19 with broad range of initiatives

Read More

January

Media Release / Jan 31, 2020

Sandoz completes acquisition of Aspen’s Japanese operations, strengthening its position in world’s third largest market for generics and off-patent medicines

Read More
Media Release / Jan 30, 2020

Sandoz officially recognized as Global Top Employer 2020

Read More
Media Release / Jan 29, 2020

Novartis delivered strong sales growth, margin expansion and breakthrough innovation launching five NMEs in 2019

Read More
2019

November

Media Release / Nov 12, 2019

Sandoz presents real-world data showing effectiveness of Erelzi® (etanercept-szzs) in rheumatic disease treatment

Read More
Media Release / Nov 11, 2019

Sandoz announces agreement to acquire Aspen’s Japanese operations and associated assets, strengthening position in world’s third largest generics market

Read More
Media Release / Nov 05, 2019

Sandoz receives US FDA approval for long-acting oncology supportive care biosimilar ZiextenzoTM (pegfilgrastim-bmez)

Read More

October

Media Release / Oct 22, 2019

Novartis delivered another strong quarter with double digit sales growth and core1 margin expansion; 2019 sales and profit guidance raised; Beovu launched in US

Read More

September

Media Release / Sep 03, 2019

Sandoz announces global deal to commercialize proposed biosimilar natalizumab, a key multiple sclerosis medicine

Read More